Category Archives: A/m resistance
Report on the GARP-Nepal meeting, December 2014 where the Nepal Situation Analysis and Recommendations (2014) was discussed by a multi-disciplinary group. Professor Buddha Basnyat is the chair of the Global Antibiotic Resistance Partnership (GARP)-Nepal working group. The report recommends the following:
Focus on Control of AMR at Nepal Society for Internal Medicine (SIMON) conference 2015- links to WHO resources
The SIMON conference next week (23-25th April) will examine the AMR problem globally and within Nepal and discuss necessary control approaches. Dr Abdul Ghafur from Chennai (behind the Chennai Declaration) will be participating. Key references include: 1. The WHO Draft Global … Continue reading
A cautionary tale: High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus
Originally posted on AIMED – Let's talk about antibiotics:
Clinical Infectious Diseases 2014 New Zealand report Researchers from the University of Auckland report that New Zealand, has now developed world’s highest rates of MRSA to topical antibacterial agents. Rates of resistance to the…
TUTH IOM symposium 5Dec2014b Please find selected abstracts of this important meeting which highlighted the collaboration between the Institute of Medicine, Kathmandu, Nepal and the National Center for Global Health and Medicine , Tokyo, Japan.
Preparation of cumulative antibiograms that describe local bacterial susceptibility patterns is an essential requirement for sensible empirical antibiotic prescribing and guideline development. Over coming weeks, I will share learnings from Australia where all hospitals are compiling antibiograms that are in accord … Continue reading
PhD candidate Basudah Shrestha gave an excellent presentation of her initial findings at a symposium celebrating the IOM, TU collaboration with NCGM, Tokyo, Japan on Dec 5th 2014 at the Institute of Medicine, KMD.
The notion that completing the course of an antibiotic reduces the emergence of bacterial resistance is not accepted anymore. From in vitro evidence, we know that prolonged exposure to antibiotic, particularly at low levels (as occurs for instance in the oropharynx … Continue reading